Company PledPharma AB (publ) Nasdaq Stockholm
Equities
SE0003815604
Biotechnology & Medical Research
Business Summary
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Emcitate
100.0
%
| 22 | 97.3 % | 58 | 100.0 % | +163.01% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Germany
29.3
%
| - | - | 17 | 29.3 % | - |
Japan
25.1
%
| 1 | 2.7 % | 15 | 25.1 % | +2,316.67% |
France
10.1
%
| 4 | 17.3 % | 6 | 10.1 % | +48.72% |
Spain
8.7
%
| 3 | 15.0 % | 5 | 8.7 % | +47.06% |
Other Countries
8.1
%
| 5 | 19.9 % | 5 | 8.1 % | +4.44% |
Poland
4.5
%
| 2 | 7.5 % | 3 | 4.5 % | +52.94% |
Australia
4.3
%
| 2 | 8.4 % | 3 | 4.3 % | +31.58% |
United Kingdom
4.2
%
| 3 | 11.1 % | 2 | 4.2 % | -4.00% |
Italy
3.5
%
| 2 | 9.7 % | 2 | 3.5 % | -9.09% |
Sweden
2.3
%
| 2 | 8.4 % | 1 | 2.3 % | -31.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 17-06-15 | |
Yilmaz Mahshid
DFI | Director of Finance/CFO | 45 | 17-12-30 |
Chief Tech/Sci/R&D Officer | - | 22-05-04 | |
Anna Sjögren
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
Chief Tech/Sci/R&D Officer | 56 | 23-02-28 | |
Henrik Krook
COO | Chief Operating Officer | 51 | 20-11-05 |
Director/Board Member | 50 | 19-12-31 | |
Karl Hård
IRC | Investor Relations Contact | 62 | 22-01-31 |
Nils Hallén
HRO | Human Resources Officer | 56 | 22-12-31 |
- | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mats Blom
CHM | Chairman | 59 | 21-03-31 |
Director/Board Member | 50 | 19-12-31 | |
Thomas Lönngren
BRD | Director/Board Member | 73 | 21-03-31 |
Director/Board Member | 63 | 16-12-31 | |
Director/Board Member | 63 | 16-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 292,571,459 | 158,682,688 ( 54.24 %) | 0 | 54.24 % |
Company contact information
![address PledPharma AB (publ)](https://cdn.zonebourse.com/static/address/10048190.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+16.49% | 122B | |
+21.73% | 115B | |
+21.69% | 26.64B | |
-21.81% | 19.91B | |
-16.87% | 16.32B | |
-44.74% | 15.52B | |
-18.81% | 15.49B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |